The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Tonix Pharmaceuticals Holding's share price is $0.1717.
Tonix Pharmaceuticals Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.32. Hence, Tonix Pharmaceuticals Holding's PS Ratio for today is 0.53.
Good Sign:
Tonix Pharmaceuticals Holding Corp stock PS Ratio (=0.38) is close to 1-year low of 0.38
The historical rank and industry rank for Tonix Pharmaceuticals Holding's PS Ratio or its related term are showing as below:
TNXP'
s PS Ratio Range Over the Past 10 Years
Min: 0.49 Med: 1.15 Max: 2.25
Current: 0.53
During the past 13 years, Tonix Pharmaceuticals Holding's highest PS Ratio was 2.25. The lowest was 0.49. And the median was 1.15.
TNXP's PS Ratio is ranked better than 95.6% of 1000
companies
in the Biotechnology industry
Industry Median: 9.095
vs TNXP: 0.53
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tonix Pharmaceuticals Holding's PS Ratio
For the Biotechnology subindustry, Tonix Pharmaceuticals Holding's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tonix Pharmaceuticals Holding's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tonix Pharmaceuticals Holding's PS Ratio distribution charts can be found below:
* The bar in red indicates where Tonix Pharmaceuticals Holding's PS Ratio falls into.
Tonix Pharmaceuticals Holding PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Tonix Pharmaceuticals Holding's Share Price of today is $0.1717. Tonix Pharmaceuticals Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Tonix Pharmaceuticals Holding (NAS:TNXP) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Tonix Pharmaceuticals Holding PS Ratio Related Terms
Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Tonix Pharmaceuticals Holding (Tonix Pharmaceuticals Holding) Business Description
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNXP has been successfully added to your 